Innovative Payment Models: An Analysis of the Promise and Practice of Novel HCV Medication Procurement Strategies in the U.S.

HEPATITIS C VIRUS (HCV) INFECTIONS continue to be a public health threat in the United States. Several states have invested in innovative payment models to help eliminate cost and access barriers to HCV treatment for people on Medicaid and people in state-operated correctional systems. So far, Louisiana and Washington have implemented innovative payment models for treatment, and Michigan is currently taking steps to implement its model.

Read more here.